Heart failure with preserved ejection fraction: uncertainties and dilemmas-Reference-Cited by-同舟云学术

Heart failure with preserved ejection fraction: uncertainties and dilemmas

Published:2015-06-16 Issue:7 Volume:17 Page:665-671
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ferrari Roberto¹,Böhm Michael²,Cleland John G.F.³,Paulus Walter J.S.⁴,Pieske Burkert⁵,Rapezzi Claudio⁶,Tavazzi Luigi⁷

Affiliation:

1. Department of Cardiology and LTTA Centre; University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care & Research, ES Health Science Foundation; Cotignola Italy

2. Universitätsklinikum des Saarlandes; Klinik für Innere Medizin III; Homburg/Saar Germany

3. National Heart & Lung Institute; Harefield Hospital, Imperial College; London UK

4. VU University Medical Center; Amsterdam The Netherlands

5. Department of Cardiology, Medical University Graz, and Ludwig-Boltzmann-Institute; Translational HF Research; Graz Austria

6. Cardiology, Department of Experimental Diagnostic and Specialty Medicine; Alma Mater-University of Bologna; Italy

7. Maria Cecilia Hospital; GVM Care & Research, ES Health Science Foundation; Cotignola Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference77 articles.

1. The pathogenesis of acute pulmonary edema associated with hypertension;Gandhi;N Engl J Med,2001

2. HFNEF, HFpEF, HF-PEF, or DHF: what is in an acronym?;Sanderson;JACC Heart Fail,2014

3. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

4. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure;Iwanaga;J Am Coll Cardiol,2006

5. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial;McKelvie;J Card Fail,2010

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the complexity of heart failure with preserved ejection fraction and secondary mitral regurgitation;European Journal of Heart Failure;2024-08-15

2. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction;European Journal of Pharmacology;2023-12

3. Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling;PLOS Computational Biology;2023-11-13

4. Characterization of a robust mouse model of heart failure with preserved ejection fraction;American Journal of Physiology-Heart and Circulatory Physiology;2023-08-01

5. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms;Frontiers in Cardiovascular Medicine;2023-07-04